0001179110-16-030495.txt : 20161005 0001179110-16-030495.hdr.sgml : 20161005 20161005193443 ACCESSION NUMBER: 0001179110-16-030495 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161003 FILED AS OF DATE: 20161005 DATE AS OF CHANGE: 20161005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSIRIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001360886 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 710881115 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 BUSINESS PHONE: 443-545-1819 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Avendano Rodrigo Alberto CENTRAL INDEX KEY: 0001686737 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32966 FILM NUMBER: 161923672 MAIL ADDRESS: STREET 1: 7015 ALBERT EINSTEIN DRIVE CITY: COLUMBIA STATE: MD ZIP: 21046 3 1 edgar.xml FORM 3 - X0206 3 2016-10-03 0 0001360886 OSIRIS THERAPEUTICS, INC. OSIR 0001686737 Avendano Rodrigo Alberto C/O OSIRIS THERAPEUTICS, INC. 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 0 1 0 0 Chief Medical Officer Incentive Stock Option (right to buy) 4.96 2017-10-03 2026-10-03 Common Stock 20000 D Options to purchase 20,000 shares of common stock of the Registrant shall become exercisable with respect to the underlying shares as to 25% on each October 3, 2017, 2018, 2019 and 2020, assuming the Reporting Person continues to be employed by the Registrant on the vesting date. Rodrigo Alberto Avendano 2016-10-05